Zobrazeno 1 - 10
of 5 246
pro vyhledávání: '"Renal impairment"'
Autor:
Chris Ho-Ming Wong, Kang Liu, Hongda Zhao, Kubilay Sabuncu, Rahim Horuz, Selami Albayrak, Maria del Pilar, Laguna Pes, Jean de la Rosette, Jeremy Yuen-Chun Teoh
Publikováno v:
BMC Urology, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Objective This study aims to explore the relationship between pre-existing renal impairment and oncological outcomes in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy (RNU) using data from a multicen
Externí odkaz:
https://doaj.org/article/3fc832f3158346f29190782e3d91b6c5
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract Trifluridine/tipiracil (FTD/TPI) with or without bevacizumab is an effective treatment for metastatic colorectal cancer (mCRC). As this agent is mainly excreted via the kidney, we aimed to evaluate the impact of renal impairment (RI) on the
Externí odkaz:
https://doaj.org/article/aadfc24014774c979c95a472172d6834
Autor:
Hanzhen Zhao, Lian Tang, Zhiwei Zhuang, Ying Zhang, Jingjing Li, Lufen Duan, Lu Shi, Chenqi Zhu, Jian Lu, Yunlong Yuan, Qian Zhang, Yanxia Yu, Jinhui Xu
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract A nomogram to estimate the risk of linezolid-induced thrombocytopenia in patients with renal impairment is not available. The aim of the study is to develop a nomogram for predicting linezolid-induced thrombocytopenia in patients with renal
Externí odkaz:
https://doaj.org/article/7f2fb51bb68b403e8346a285689f0e8e
Autor:
Chu-Wen Fang, Hui-Lung Hsieh, Shuo-Meng Wang, Kuo-How Huang, Kang-Yung Peng, Yen-Hung Lin, Vin-Cent Wu, Jeff S. Chueh
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Primary aldosteronism (PA), which is present in 5–18% of hypertensive patients, is a leading cause of secondary hypertension. Adrenalectomy is often recommended for patients with unilateral primary aldosteronism (uPA), yielding
Externí odkaz:
https://doaj.org/article/d5b86ea7c9c349c098f7c959c6a641fd
Publikováno v:
Blood and Lymphatic Cancer: Targets and Therapy, Vol Volume 14, Pp 49-62 (2024)
Yingzi Zhang,1 Xiajuan Yao,1 Yaoquan Zhang,1 Zhuyun Chen,1 Zhongke Qin,1 Ying Cai,2 Wenkai Xia,1 Hong Hu1 1Department of Nephrology, Jiangyin People’s Hospital Affiliated to Nantong University, Jiangyin, Jiangsu, 214400, People’s Republic of Chin
Externí odkaz:
https://doaj.org/article/37ce1963e3f04ea0b9c4ceebae767d1a
Autor:
Batsaikhan Batsuuri, Shiirevnyamba Avirmed, Chuluunbileg Batbold, Fidel Lopez-Verdugo, Jade Nunez, Ariunaa Togtokh, Sergelen Orgoi
Publikováno v:
Clinical Transplantation and Research, Vol 38, Iss 2, Pp 128-135 (2024)
Background : Renal impairment (RI) is a frequent complication of liver cirrhosis and is associated with increased mortality and morbidity. Liver transplantation (LT) serves as an effective treatment method for patients with cirrhosis who have impaire
Externí odkaz:
https://doaj.org/article/fa6918981f654360a2071b1db2c3e906
Autor:
Sindhu N. Samba, Youssef Daklallah, Sydney E. S. Brown, Douglas A. Colquhoun, Zubin J. Modi, Rebecca Nause-Osthoff
Publikováno v:
BMC Anesthesiology, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Sugammadex is a pharmacologic agent that provides rapid reversal of neuromuscular blockade via encapsulation of the neuromuscular blocking agent (NMBA). The sugammadex-NMBA complex is primarily cleared through glomerular filtratio
Externí odkaz:
https://doaj.org/article/c6463bf5279e4d5f972ff2c9e0064aac
Publikováno v:
Clinical Interventions in Aging, Vol Volume 19, Pp 1017-1028 (2024)
Xiangping Cheng,1,2,* Boyu Chen,3,* Xiaoyan Chen,4,* Zhi Song,2 Jie Li,2 Jiacheng Huang,4 Weilin Kong,4 Jinglun Li1 1Department of Neurology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, People’s Re
Externí odkaz:
https://doaj.org/article/92620c7808ff4675aa285988ecad7523
Publikováno v:
Asian Journal of Medical Sciences, Vol 15, Iss 6, Pp 119-123 (2024)
Background: Rivaroxaban is a widely used anticoagulant, but its impact on renal function, particularly at varying plasma concentrations, remains a critical area of investigation. This study examines the relationship between rivaroxaban concentration
Externí odkaz:
https://doaj.org/article/1acdabaff36946e799ad4f9b2bdc3c96